Adrian Shephard Selected Research

Pharyngitis (Sore Throat)

7/2021	Evidence of the Efficacy of Flurbiprofen 8.75 mg Lozenges for Patients Receiving Antibiotics for Laboratory-Confirmed Streptococcal Pharyngitis.
10/2020	Point-of-Care Testing for Pharyngitis in the Pharmacy.
7/2020	Refinement and further application of the Qualities of Sore Throat Index (QuaSTI).
2/2020	Bactericidal activity of hexylresorcinol lozenges against oropharyngeal organisms associated with acute sore throat.
1/2020	Patients with Sore Throat: A Survey of Self-Management and Healthcare-Seeking Behavior in 13 Countries Worldwide.
1/2020	Inhibition of viral and bacterial trigger-stimulated prostaglandin E2 by a throat lozenge containing flurbiprofen: An in vitro study using a human respiratory epithelial cell line.
12/2019	Topical (local) antibiotics for respiratory infections with sore throat: An antibiotic stewardship perspective.
1/2019	Locally Delivered Flurbiprofen 8.75 mg for Treatment and Prevention of Sore Throat: A Narrative Review of Clinical Studies.
11/2018	Onset of analgesia by a topically administered flurbiprofen lozenge: a randomised controlled trial using the double stopwatch method.
3/2018	Qualities of Sore Throat Index (QuaSTI): measuring descriptors of sore throat in a randomized, placebo-controlled trial.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Adrian Shephard Research Topics

Disease

25	Pharyngitis (Sore Throat) 07/2021 - 02/2011
9	Pain (Aches) 07/2021 - 02/2014
8	Respiratory Tract Infections (Respiratory Tract Infection) 12/2019 - 02/2011
3	Infections 10/2020 - 12/2019
2	Inflammation (Inflammations) 01/2020 - 01/2016
1	Streptococcal Infections (Streptococcal Infection) 07/2021
1	Allergic Rhinitis 01/2021
1	Disorders of Excessive Somnolence (Hypersomnia) 01/2021
1	Human Influenza (Influenza) 01/2018
1	Virus Diseases (Viral Diseases) 06/2016
1	Snoring 10/2012
1	Hypesthesia (Numbness) 01/2012

Drug/Important Bio-Agent (IBA)

13	Flurbiprofen (Froben)FDA LinkGeneric 07/2021 - 02/2013
10	Anti-Bacterial Agents (Antibiotics)IBA 07/2021 - 02/2013
5	Analgesics (Analgesic Drugs)IBA 07/2021 - 02/2011
5	amylmetacresolIBA 01/2018 - 02/2011
5	2',4'-dichlorobenzamil amiloride (DCBA)IBA 01/2018 - 02/2011
3	HexylresorcinolIBA 02/2020 - 01/2012
3	Pharmaceutical PreparationsIBA 01/2019 - 02/2014
3	dichlorobenzyl alcoholIBA 01/2018 - 02/2011
2	Therapeutic UsesIBA 07/2020 - 03/2018
2	Local Anti-Infective Agents (Antiseptics)IBA 02/2020 - 01/2018
1	Histamine Antagonists (Antihistamines)IBA 01/2021
1	Triprolidine (Actidil)FDA Link 01/2021
1	Dinoprostone (PGE2)FDA Link 01/2020
1	LipopolysaccharidesIBA 01/2020
1	Peptidoglycan (Murein)IBA 01/2020
1	TyrothricinIBA 12/2019
1	Neomycin FDA LinkGeneric 12/2019
1	Gramicidin (Gramicidin A)FDA LinkGeneric 12/2019
1	Bacitracin (Baci-Rx)FDA LinkGeneric 12/2019
1	Artificial SalivaIBA 01/2018
1	Antiviral Agents (Antivirals)IBA 11/2015
1	Pharmacologic ActionsIBA 07/2014
1	Air Pollutants (Pollutants, Air)IBA 10/2012
1	Biomarkers (Surrogate Marker)IBA 10/2012
1	Dihydrotachysterol (AT 10)IBA 01/2012
1	Lidocaine (Xylocaine)FDA LinkGeneric 01/2012

Therapy/Procedure

1	Aftercare (After-Treatment) 02/2014
1	Therapeutics 02/2013